Market Closed -
Other stock markets
|
|
Pre-market 07:39:25 am | ||
310.42 USD | -0.37% | 311 | +0.19% |
Dec. 04 | Morgan Stanley Raises Intuitive Surgical Price Target to $330 From $300, Maintains Equal Weight Rating | MT |
Nov. 21 | It’s Nvidia Day | ![]() |
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (56.5%): primarily wrist cuffs;
- sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.5%).
The United States accounts for 66.8% of net sales.
Calendar
2024-01-24
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
310.42USD
Average target price
327.83USD
Spread / Average Target
+5.61%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.99% | 109 B $ | |
-11.06% | 189 B $ | |
-18.06% | 161 B $ | |
+18.76% | 80 501 M $ | |
+11.88% | 63 269 M $ | |
-6.32% | 49 971 M $ | |
-7.28% | 41 958 M $ | |
-15.00% | 37 158 M $ | |
+17.37% | 31 193 M $ | |
-21.75% | 23 955 M $ |
- Stock
- Equities
- Stock Intuitive Surgical, Inc. - Nasdaq
- News Intuitive Surgical, Inc.
- Morningstar Raises Intuitive Surgical's Price Target to $230 From $204, Sell Rating Kept